Image pharmaphorum Editor Debates & Insight Sponsored Brexit - What now for pharma? Join us for a one-hour live webinar entitled Brexit - What now for pharma? Debates & Insight Sponsored Available on demand: Measuring the cost of the right interve... Available on Demand: Measuring the cost of the right interventions in diabetes. Debates & Insight Sponsored From ideals to execution: the reality of patient-centricity ... Debates & Insight Sponsored Available on demand: What will changes to England's pharmacy... New measures proposed by the Government will impact community pharmacies across the UK. Load more results
Debates & Insight Sponsored Brexit - What now for pharma? Join us for a one-hour live webinar entitled Brexit - What now for pharma?
Debates & Insight Sponsored Available on demand: Measuring the cost of the right interve... Available on Demand: Measuring the cost of the right interventions in diabetes.
Debates & Insight Sponsored Available on demand: What will changes to England's pharmacy... New measures proposed by the Government will impact community pharmacies across the UK.
News MSD takes a $400m bite of SciBrunch's KRAS drug MSD has signed a license agreement for a KRAS G12D inhibitor from China's SciBrunch, paying $400m upfront for the preclinical candidate.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
